Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests

January 18, 2018 from 1:00 – 2:00 PM ET

View WebinarExternal Web Site Policy

PowerPoint Presentation (PDF, 442 KB)

FAQs (PDF, 134 KB)

Speaker:

Erica S. Breslau Erica S. Breslau, Ph.D., M.P.H.
Program Director
Health Systems and Interventions Research Branch
Healthcare Delivery Research Program
Division of Cancer Control and Population Sciences

Summary:

This webinar provides an overview of the Funding Opportunity Announcement (FOA), Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional) [PA-17-495]External Web Site Policy. This FOA encourages applications that develop and test multilevel interventions to improve follow-up to abnormal screening tests for breast, cervical, colorectal, or lung cancers. Applications should propose to intervene at two or more levels—including patient, provider, clinical team, clinic, healthcare institution, and/or community setting—and measure outcomes at three or more levels, while accounting for interactions that occur between and across levels.